The global Liposome Drug Delivery market was valued at USD 5.31 billion in 2024 and is expected to reach USD 10.20 billion by 2032
During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 8.50 %, primarily driven by the rising demand for targeted drug delive